Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

L-dopa modulates functional connectivity in striatal cognitive and motor networks: a double-blind placebo-controlled study.

Kelly C, de Zubicaray G, Di Martino A, Copland DA, Reiss PT, Klein DF, Castellanos FX, Milham MP, McMahon K.

J Neurosci. 2009 Jun 3;29(22):7364-78. doi: 10.1523/JNEUROSCI.0810-09.2009.

2.

Dopamine release in dissociable striatal subregions predicts the different effects of oral methylphenidate on reversal learning and spatial working memory.

Clatworthy PL, Lewis SJ, Brichard L, Hong YT, Izquierdo D, Clark L, Cools R, Aigbirhio FI, Baron JC, Fryer TD, Robbins TW.

J Neurosci. 2009 Apr 15;29(15):4690-6. doi: 10.1523/JNEUROSCI.3266-08.2009.

3.

Elevated striatal dopamine function linked to prodromal signs of schizophrenia.

Howes OD, Montgomery AJ, Asselin MC, Murray RM, Valli I, Tabraham P, Bramon-Bosch E, Valmaggia L, Johns L, Broome M, McGuire PK, Grasby PM.

Arch Gen Psychiatry. 2009 Jan;66(1):13-20. doi: 10.1001/archgenpsychiatry.2008.514.

PMID:
19124684
4.

Spontaneous movement disorders in antipsychotic-naive patients with first-episode psychoses: a systematic review.

Pappa S, Dazzan P.

Psychol Med. 2009 Jul;39(7):1065-76. doi: 10.1017/S0033291708004716. Epub 2008 Nov 12. Review.

PMID:
19000340
5.

Neurocomputational models of basal ganglia function in learning, memory and choice.

Cohen MX, Frank MJ.

Behav Brain Res. 2009 Apr 12;199(1):141-56. doi: 10.1016/j.bbr.2008.09.029. Epub 2008 Oct 4. Review.

6.

Neurocognition and conversion to psychosis in adolescents at high-risk.

Walder DJ, Mittal V, Trotman HD, McMillan AL, Walker EF.

Schizophr Res. 2008 Apr;101(1-3):161-8. doi: 10.1016/j.schres.2007.12.477. Epub 2008 Feb 20.

7.

Longitudinal progression of movement abnormalities in relation to psychotic symptoms in adolescents at high risk of schizophrenia.

Mittal VA, Neumann C, Saczawa M, Walker EF.

Arch Gen Psychiatry. 2008 Feb;65(2):165-71. doi: 10.1001/archgenpsychiatry.2007.23.

PMID:
18250254
8.

Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America.

Cannon TD, Cadenhead K, Cornblatt B, Woods SW, Addington J, Walker E, Seidman LJ, Perkins D, Tsuang M, McGlashan T, Heinssen R.

Arch Gen Psychiatry. 2008 Jan;65(1):28-37. doi: 10.1001/archgenpsychiatry.2007.3.

9.

Prenatal exposure to viral infection and conversion among adolescents at high-risk for psychotic disorders.

Mittal VA, Saczawa ME, Walker E, Willhite R, Walder D.

Schizophr Res. 2008 Feb;99(1-3):375-6. doi: 10.1016/j.schres.2007.11.037. Epub 2007 Dec 31. No abstract available.

10.

Movement abnormalities predict conversion to Axis I psychosis among prodromal adolescents.

Mittal VA, Walker EF.

J Abnorm Psychol. 2007 Nov;116(4):796-803.

PMID:
18020725
11.

Neurocognitive deficits in the (putative) prodrome and first episode of psychosis.

Eastvold AD, Heaton RK, Cadenhead KS.

Schizophr Res. 2007 Jul;93(1-3):266-77. Epub 2007 Apr 30.

12.

The course of neurocognition and social functioning in individuals at ultra high risk for psychosis.

Niendam TA, Bearden CE, Zinberg J, Johnson JK, O'Brien M, Cannon TD.

Schizophr Bull. 2007 May;33(3):772-81. Epub 2007 Apr 9.

13.

Cognitive functioning in the schizophrenia prodrome.

Simon AE, Cattapan-Ludewig K, Zmilacher S, Arbach D, Gruber K, Dvorsky DN, Roth B, Isler E, Zimmer A, Umbricht D.

Schizophr Bull. 2007 May;33(3):761-71. Epub 2007 Apr 4.

14.

Circuits and circuit disorders of the basal ganglia.

DeLong MR, Wichmann T.

Arch Neurol. 2007 Jan;64(1):20-4. Review.

PMID:
17210805
15.

The relations among putative biorisk markers in schizotypal adolescents: minor physical anomalies, movement abnormalities, and salivary cortisol.

Mittal VA, Dhruv S, Tessner KD, Walder DJ, Walker EF.

Biol Psychiatry. 2007 May 15;61(10):1179-86. Epub 2006 Dec 22.

PMID:
17188254
16.

A longitudinal study of neurocognitive function in individuals at-risk for psychosis.

Keefe RS, Perkins DO, Gu H, Zipursky RB, Christensen BK, Lieberman JA.

Schizophr Res. 2006 Dec;88(1-3):26-35. Epub 2006 Aug 22.

PMID:
16930949
17.

Generalized and specific cognitive performance in clinical high-risk cohorts: a review highlighting potential vulnerability markers for psychosis.

Brewer WJ, Wood SJ, Phillips LJ, Francey SM, Pantelis C, Yung AR, Cornblatt B, McGorry PD.

Schizophr Bull. 2006 Jul;32(3):538-55. Epub 2006 Jun 16. Review.

18.

Cognitive function and symptoms in adolescents with schizotypal personality disorder.

Trotman H, McMillan A, Walker E.

Schizophr Bull. 2006 Jul;32(3):489-97. Epub 2006 Apr 12.

19.

Neurocognitive performance and functional disability in the psychosis prodrome.

Niendam TA, Bearden CE, Johnson JK, McKinley M, Loewy R, O'Brien M, Nuechterlein KH, Green MF, Cannon TD.

Schizophr Res. 2006 May;84(1):100-11. Epub 2006 Mar 24.

PMID:
16563699
20.

Intellectual decline in schizophrenia: evidence from a prospective birth cohort 28 year follow-up study.

Seidman LJ, Buka SL, Goldstein JM, Tsuang MT.

J Clin Exp Neuropsychol. 2006 Feb;28(2):225-42.

PMID:
16484095
Items per page

Supplemental Content

Write to the Help Desk